Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Aug 18.
Published in final edited form as: Pediatrics. 2022 Jun 1;149(6):e2022057529. doi: 10.1542/peds.2022-057529

Recommended Terminology for Substance Use Disorders in the Care of Children, Adolescents, Young Adults, and Families

Rachel H Alinsky a, Scott E Hadland b, Joanna Quigley c, Stephen W Patrick d; COMMITTEE ON SUBSTANCE USE AND PREVENTION
PMCID: PMC9386168  NIHMSID: NIHMS1811093  PMID: 35977095

Abstract

Pediatricians across the United States encounter infants, children, adolescents, young adults, and families affected by substance use disorders in their daily practice. For much of history, substance use has been viewed as a moral failing for which individuals themselves are to blame; however, as addiction became understood as a medical disorder, clinical terminology has shifted along with a growing awareness of harm of stigmatizing language in medicine. In issuing this policy statement, the American Academy of Pediatrics (AAP) joins other large organizations in providing recommendations regarding medically accurate, person-first, and nonstigmatizing terminology. As the first pediatric society to offer guidance on preferred language regarding substance use to be used among pediatricians, media, policymakers, and government agencies and in its own peer-reviewed publications, the AAP aims to promote child health by highlighting the specific context of infants, children, adolescents, young adults, and families. In this policy statement, the AAP provides 3 specific recommendations, accompanied by a table that presents a summary of problematic language to be avoided, paired with the recommended more appropriate language and explanations for each. Pediatricians have an important role in advocating for the health of children and adolescents in the context of families affected by substance use and are optimally empowered to do so by avoiding the use of stigmatizing language in favor of medically accurate terminology that respects the dignity and personhood of individuals with substance use disorders and the children and adolescents raised in families affected by substance use.


Pediatricians across the United States encounter infants, children, adolescents, and families affected by substance use disorders (SUDs) in their daily practice. Amid the national overdose crisis, the rise of widespread cannabis and e-cigarette availability, and persistently high prevalence of alcohol use, there is a renewed focus on recognition and treatment of SUDs. In previous policy statements, the American Academy of Pediatrics (AAP)1 recognized the unique role of pediatricians in identifying and responding to familial substance use and has highlighted the importance of doing so in an empathetic, respectful, and supportive manner. Fundamental to this practice is an appreciation of the impact of language itself, with particular care paid to the terminology used in interactions with patients, family, and the public and in written materials.

A substantial hurdle to compassionately caring for patients and families affected by substance use is the widespread stigma against people with SUDs. For much of history, substance use has been viewed as a moral failing for which individuals themselves are to blame, particularly individuals of color.26 Stigmatizing language reflecting this implicit bias and moralistic view, such as “substance abuse,” “drug abuser,” and “addict,” have been commonplace not only in general conversation and the lay press7 but also in medical literature.8 Many of these pejorative terms have racist connotations, and derogatory terms like “crack babies” carry with them decades of legislation targeting communities of color with a carceral response to substance use, such as the War on Drugs.5,6 In the face of the increasing prevalence of the use of opioids, marijuana, and novel psychoactive substances, the medical community has recognized a great deal of scientific evidence revealing that addiction is a chronic illness that has the potential for recurrence similar to other medical conditions and is not a moral failing.9

As addiction became understood as a medical disorder, clinical terminology shifted, including that in the Diagnostic and Statistical Manual of Mental Disorders (DSM). Previous versions of the DSM used the phrase “substance abuse”;10 however, the DSM-V uses the less stigmatizing term “substance use disorder,” recognizing the chronic disease nature of addiction.11 This shift in DSM nomenclature aligned with a growing awareness of the power of stigmatizing language in medicine. The use of derogatory terms such as “substance abuse” and “substance abuser” has been shown to negatively affect both lay community members’ and health care providers’ perceptions of individuals who use substances,3,1217 resulting in the view that these individuals need punishment as opposed to help or treatment. These internalized perceptions have tangible effects, as evidenced by a systematic review that found that health care providers’ negatively biased views of individuals with SUDs result in worse health care delivery.18

In response to this evidence, the US government, as well as major scientific and journalism organizations, continue to issue statements guiding the use of appropriate language in the discussion of substance use and SUDs, including:

  • The American Society of Addiction Medicine1921

  • Association for Multidisciplinary Education and Research in Substance Use and Addiction22,23

  • American Medical Association24

  • International Society for Addiction Journal Editors25,26

  • The White House27

  • National Institutes of Health28

  • Associated Press29

  • Columbia Journalism Review30

  • National Academies of Science, Engineering, and Medicine4,31

THE PEDIATRIC CONTEXT

As the first pediatric society to offer guidance on preferred language regarding substance use to be used among pediatricians, media, policymakers, government agencies, and in its own peer-reviewed publications, the AAP aims to promote child health by highlighting the specific context of children, adolescents, and families. Pediatricians have an essential role in the prevention of, treatment of, and advocating for infants, children, adolescents, and young adults affected by substance use. They are empowered to do so by actively working to dismiss harmful stereotypes and avoiding the use of stigmatizing language in favor of medically accurate terminology that respects the dignity and personhood of individuals with substance use disorders and the children and adolescents raised in families affected by substance use.

Table 1 presents a summary of problematic language to be avoided, paired with the recommended more appropriate language and an explanation. The table is organized into 3 main topics. The first topic pertains to terminology regarding substance use, specifically covering the medically accurate diagnostic terminology for substance use disorders.

TABLE 1.

Recommended Terminology Regarding Substance Use

Say This: Not This: Here’s Why:
Terminology regarding substance use
 Substance use disorder; [insert specific substance: opioid, cocaine, alcohol, etc] use disorder
 Addiction
Drug abuse/dependence
Substance abuse/dependence
The diagnostic terms “substance abuse” and “substance dependence” described in the DSM-IV have been combined in the DSM-V into “substance use disorder.” “Abuse” and “dependence” should only be used in specific reference to DSM-IV or earlier criteria or when using ICD-10 nomenclature, which still use the term “dependence;” “addiction” may also be used in conjunction with a severe substance use disorder.
 Substance use
 Hazardous substance use
 Unhealthy substance use
 Problematic substance use
Substance abuse
Drug habit
Vice
Substance use exists on a continuum, not all of which constitutes a diagnosable substance use disorder; therefore, these terms describe substance use that risks health consequences or is in excess of current safe use guidelines, without necessarily referencing or meeting criteria for a substance use disorder; it is more precise in describing health hazard than simply “misuse.” Of note, any substance use in adolescents is considered unhealthy.
 Nonmedical prescription opioid use
 Nonmedical prescription drug use
 Nonmedical prescription medication use
Prescription opioid abuse
Prescription drug abuse
Refers to using opioids or other prescription drugs in a way other than as prescribed or by a person to whom they were not prescribed.
 Intoxicated or in withdrawal Using Strung out, tweaking, high, drunk (and other colloquial substance-specific terms)
Getting high
Uses medically accurate language to describe the state of intoxication or withdrawal from a substance.
Less stigmatizing way to describe the act of using a substance to reach intoxication.
 Drinking Getting drunk
Terminology regarding persons
 Person with a substance use disorder
 Person who uses [insert specific substance: opioid, cocaine, alcohol, etc]
Substance/drug abuser, addict, junkie, druggie, stoner, alcoholic, drunk (and other colloquial substance-specific terms)
Drug user, heroin user, drinker, crackhead, pothead, drug-seeking (and other colloquial substance-specific terms)
Uses person-first language, as individuals are not defined solely by their substance use. If unsure of whether the individual has a diagnosed disorder, then the description of “a person who uses [insert specific substance]” is most appropriate.
 Person who injects drugs (PWID)
 Treatment was not effective
 Patient in need of more support/higher level of treatment
Injection drug user
Patient who failed treatment
Noncompliant, nonadherent
Referring to the treatment not meeting the needs of the patient or the patient needing a higher level of treatment, rather than the patient failing.
 Person with multiple recurrences
 Person with multiple treatment admissions
Frequent flyer
Recidivist
Less stigmatizing way to denote someone with recurrence of substance use disorder, rather than referencing it as a criminal offense or a relapse, which is associated with the connotation of more blame.
 Infant/baby with neonatal withdrawal syndrome
 Infant/baby born substance-exposed
 Infant/baby with physiologic dependence/withdrawal
 Concerned loved one
Addicted baby
Born addicted
Drug endangered
Neonatal abstinence syndrome baby or NAS baby Crack baby
Enabler
Substance use disorders, characterized by repeated use despite harmful consequences, cannot be diagnosed in an infant; an infant can develop physiologic dependence to a substance such as opioids, for which the medical term is neonatal opioid withdrawal syndrome or neonatal withdrawal.
Less stigmatizing way to describe a loved one who supports someone with a substance use disorder and at times may protect them from the negative consequences of their substance use.
Terminology regarding treatment
 Treatment, pharmacotherapy
 Medication for addiction treatment (MAT)
 Medication for opioid use disorder (MOUD)
Medication-assisted treatment (MAT)
Opioid substitution therapy
Opioid replacement therapy
Medication is treatment and should not be referenced as “assisting” some other treatment, or as simply substituting one opioid for another; if use of acronym “MAT” is desired, recommend using it to refer to term “medication for addiction treatment.”
 In early remission
 In sustained remission
 In recovery
 Entered recovery
 Stopped using substances
 Engaged in treatment
Clean
Got clean
People with a history of substance use who are not currently using are deemed “in remission” or “in recovery,” more neutral words than “clean” which implies that people actively using substances are “dirty.”
 Negative versus positive test result [Insert substance] detected Clean versus dirty test/urine Refer to the actual results of the toxicology test, rather than “clean” and “dirty,” which imply judgment.

ICD-10, International Classification of Diseases and Related Health Problems, 10th Edition.

The second topic in the table relates to the use of “person-first” language that first and foremost acknowledges the innate personhood of an individual, rather than defining someone primarily on the basis of a condition or characteristic (in this case, substance use). The use of person-first (or people-first) language is consistent with the standard set in previous AAP policy statements for describing individuals with other chronic medical conditions or disabilities, such as “a child with diabetes” rather than “a diabetic.”32 A special circumstance to highlight in this section is the problematic language that has been used to describe infants born substance-exposed who, in the lay press and elsewhere, have commonly and inappropriately been referred to as “born addicted.” This language and the associated intense stigma surrounding SUDs in pregnant individuals can dissuade them from seeking treatment or cause them to abruptly end treatment, leading to worse outcomes for infants and families. The medically accurate terminology for infants who have withdrawal after birth is neonatal withdrawal.33,34 This is in contrast to a substance use disorder, which, by definition, includes “a problematic pattern of substance use leading to clinically significant impairment or distress, as manifest by at least two [… maladaptive behaviors].”11 On the basis of this medical definition, infants unequivocally cannot display the behavioral patterns necessary to be “addicted” to drugs, and the use of this terminology is highly stigmatizing to families.

The last topic in the table covers terminology for use in the discussion of the treatment of SUDs. Medication for opioid use disorder has been demonstrated to be safe and effective31,35 and is recognized by the AAP, the Society for Adolescent Health and Medicine, the American Society of Addiction Medicine, and the American College of Obstetricians and Gynecologists as the recommended treatment for not only adults but also adolescents and pregnant people with an opioid use disorder.3640 For this reason, it is most accurate to refer to medication as treatment in and of itself, as opposed to “assisting” other treatment or being used as a “substitution” or “replacement” therapy. As of 2022, there are no data to suggest that the term nicotine replacement therapy is associated with stigma or that this terminology dissuades individuals from seeking medication treatment for nicotine use disorder; future studies could examine this question.

At times, patients may use some of these problematic terms to describe their own experiences. While allowing patients to choose their own language out of respect for their lived experience, pediatricians themselves should, nonetheless, continue to use the preferred terminology, because modeling accurate terminology remains valuable even in these circumstances so as not to perpetuate the intense shame often associated with SUDs. Pediatricians can also use these opportunities as a catalyst for conversations with patients and parents about reducing stigma and why using nonstigmatizing language matters.

Lastly, individuals will undoubtedly encounter problematic terms in the existing literature and even in the International Classification of Diseases and Related Health Problems, 10th Edition;41 when referencing or summarizing this literature, it is recommended to replace the problematic terms with the preferred terminology. If an exact citation is necessary, one can use quotations and the notation “[sic],” accompanied by an explanation of the outdated problematic terminology.

Recommendations

The AAP recommends the following:

  1. Pediatricians, policymakers, government agencies, and media should use medically accurate terminology as opposed to stigmatizing jargon (see Table 1) in interactions with patients, families, and the public as well as in written materials including medical record documentation, correspondence, manuscripts, editorials and opinion articles, and news stories.

  2. Pediatricians, health care facility spokespersons, policymakers, government agencies, and media should use person-first language that respects the dignity of an individual first and foremost as a person (see Table 1) in interactions with patients, families, and the public, as well as in written materials, including medical record documentation, correspondence, manuscripts, editorials and opinion articles, and news stories.

  3. Professional entities should encourage authors submitting manuscripts or materials for publication in their journals to use medically accurate and respectful person-first language (see Table 1).

Footnotes

This document is copyrighted and is property of the American Academy of Pediatrics and its board of directors. All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the board of directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.

The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

All policy statements from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no potential conflicts of interest to disclose.

REFERENCES

  • 1.Smith VC, Wilson CR; Committee on Substance Use and Prevention. Families affected by parental substance use. Pediatrics. 2016;138(2):e20161575. [DOI] [PubMed] [Google Scholar]
  • 2.Botticelli MP, Koh HK. Changing the language of addiction. JAMA. 2016; 316(13):1361–1362 [DOI] [PubMed] [Google Scholar]
  • 3.Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202–207 [DOI] [PubMed] [Google Scholar]
  • 4.National Academies of Sciences Engineering and Medicine. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change. Washington, DC: National Academies Press; 2016 [PubMed] [Google Scholar]
  • 5.Netherland J, Hansen HB. The war on drugs that wasn’t: wasted whiteness, “dirty doctors,” and race in media coverage of prescription opioid misuse. Cult Med Psychiatry. 2016;40(4):664–686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.James K, Jordan A. The opioid crisis in Black communities. J Law Med Ethics. 2018;46(2):404–421 [DOI] [PubMed] [Google Scholar]
  • 7.McGinty EE, Stone EM, Kennedy-Hendricks A, Barry CL. Stigmatizing language in news media coverage of the opioid epidemic: implications for public health. Prev Med. 2019;124:110–114 [DOI] [PubMed] [Google Scholar]
  • 8.Bailey NA, Diaz-Barbosa M. Effect of maternal substance abuse on the fetus, neonate, and child. Pediatr Rev. 2018;39(11):550–559 [DOI] [PubMed] [Google Scholar]
  • 9.U.S. Department of Health and Human Services, Office of the Surgeon General. Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: CreateSpace Independent Publishing Platform; 2017 [PubMed] [Google Scholar]
  • 10.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994 [Google Scholar]
  • 11.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013 [Google Scholar]
  • 12.Ashford RD, Brown AM, Curtis B. Substance use, recovery, and linguistics: the impact of word choice on explicit and implicit bias. Drug Alcohol Depend. 2018;189:131–138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ashford RD, Brown AM, Curtis B. “Abusing addiction”: our language still isn’t good enough. Alcohol Treat Q. 2019;37(2):257–272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ashford RD, Brown AM, McDaniel J, Curtis B. Biased labels: an experimental study of language and stigma among individuals in recovery and health professionals. Subst Use Misuse. 2019;54(8):1376–1384 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Barry CL, McGinty EE, Pescosolido BA, Goldman HH. Stigma, discrimination, treatment effectiveness and policy: public views about drug addiction and mental illness. Psychiatr Serv. 2014;65(10):1269–1272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kelly JF, Dow SJ, Westerhoff C. Does our choice of substance-related terms influence perceptions of treatment need? An empirical investigation with two commonly used terms. J Drug Issues. 2010;40(4):805–818 [Google Scholar]
  • 17.McGinty EE, Goldman HH, Pescosolido B, Barry CL. Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination. Soc Sci Med. 2015;126:73–85 [DOI] [PubMed] [Google Scholar]
  • 18.van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35 [DOI] [PubMed] [Google Scholar]
  • 19.American Society of Addiction Medicine. Terminology related to addiction, treatment, and recovery. Available at: https://www.asam.org/advocacy/find-a-policy-statement/archived-public-policy-statements/public-policy-statements/2014/08/01/terminology-related-to-addiction-treatment-and-recovery. Accessed November 11, 2021
  • 20.American Society of Addiction Medicine. Terminology related to the spectrum of unhealthy substance use. Available at: https://www.asam.org/advocacy/find-a-policy-statement/archived-public-policy-statements/public-policy-statements/2014/08/01/terminology-related-to-the-spectrum-of-unhealthy-substance-use. Accessed November 11, 2021
  • 21.American Society of Addiction Medicine. Language and terminology guidance for Journal of Addiction Medicine (JAM) manuscripts. Available at: https://journals.lww.com/journaladdictionmedicine/Pages/Instructions-and-Guidelines.aspx#languageandterminologyguidance. Accessed November 11, 2021
  • 22.Association for Multidiscplinary Education and Research in Substance Use and Addiction. Interdisciplinary addiction strategies: discover, prevent, treat, teach. In: Program of the AMERSA 42nd Annual National Conference; November 8–10, 2018; San Francisco, CA. [Google Scholar]
  • 23.Broyles LM, Binswanger IA, Jenkins JA, et al. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014; 35(3):217–221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.American Medical Association. Language matters to the American Medical Association. Available at: https://end-overdose-epidemic.org/wp-content/uploads/2020/07/Language-Matters_Template-1.pdf. Accessed June 30, 2021
  • 25.Saitz R International statement recommending against the use of terminology that can stigmatize people. J Addict Med. 2016;10(1):1–2 [DOI] [PubMed] [Google Scholar]
  • 26.Stenius K, Nesvåg S. ISAJE terminology statement. Nordic Stud Alcohol Drugs. 2015;32(5):539–540 [Google Scholar]
  • 27.Botticelli M The White House. Changing the language of addiction. Available at: https://obamawhitehouse.archives.gov/blog/2017/01/13/changing-language-addiction. Accessed November 11, 2021
  • 28.National Institute on Drug Abuse. Words matter: terms to use and avoid when talking about addiction. Available at: https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/nidamed_wordsmatter3_508.pdf. Accessed November 11, 2021
  • 29.The Associated Press. The Associated Press Stylebook 2017 and Briefing on Media Law. 52nd ed. New York, NY: Basic Books; 2017 [Google Scholar]
  • 30.Feder KA, Krawczyk N. Columbia Journalism Review. Four facts every journalist should know when covering the opioid epidemic. Columbia Journalism Review. Published online August 15, 2017. Available at: https://www.cjr.org/united_states_project/opioid-journalist-advice.php. Accessed October 17, 2020 [Google Scholar]
  • 31.National Academies of Sciences Engineering and Medicine. Medications for Opioid Use Disorder Save Lives. Washington, DC: National Academies Press; 2019 [PubMed] [Google Scholar]
  • 32.Pont SJ, Puhl R, Cook SR, Slusser W; Section on Obesity; Obesity Society. Stigma experienced by children and adolescents with obesity. Pediatrics. 2017;140(6):e20173034. [DOI] [PubMed] [Google Scholar]
  • 33.Hudak ML, Tan RC; Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–e560 [DOI] [PubMed] [Google Scholar]
  • 34.Patrick SW, Barfield WD, Poindexter BB; Committee on Fetus and Newborn, Committee on Substance Use and Prevention. Neonatal opioid withdrawal syndrome. Pediatrics. 2020;146(5):e2020029074. [DOI] [PubMed] [Google Scholar]
  • 35.Murthy VH. Surgeon General’s report on alcohol, drugs, and health. JAMA. 2017;317(2):133–134 [DOI] [PubMed] [Google Scholar]
  • 36.Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893. [DOI] [PubMed] [Google Scholar]
  • 37.American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130(2):e81–e94 [DOI] [PubMed] [Google Scholar]
  • 38.American Society of Addiction Medicine. National practice guideline for the treatment of opioid use disorder. Available at: https://www.asam.org/Quality-Science/quality/2020-national-practice-guideline. Accessed November 11, 2021 [Google Scholar]
  • 39.Patrick SW, Schiff DM; Committee on Substance Use and Prevention. A public health response to opioid use in pregnancy. Pediatrics. 2017;139(3): e20164070. [DOI] [PubMed] [Google Scholar]
  • 40.Society for Adolescent Health and Medicine. Medication for adolescents and young adults with opioid use disorder. J Adolesc Health. 2021;68(3):632–636 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. F10-F19: mental and behavioral disorders due to psychoactive substance use. Available at: https://www.who.int/substance_abuse/terminology/ICD10ClinicalDiagnosis.pdf. Accessed November 11, 2021

RESOURCES